4//SEC Filing
KYTHERA BIOPHARMACEUTICALS INC 4
Accession 0001104659-15-068867
CIK 0001436304operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 2:19 PM ET
Size
9.8 KB
Accession
0001104659-15-068867
Insider Transaction Report
Form 4
Ball F Michael
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-10-01−18,000→ 0 totalExercise: $41.95Exp: 2023-09-17→ Common Stock (18,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−11,591→ 0 totalExercise: $53.26Exp: 2025-06-02→ Common Stock (11,591 underlying) - Disposition to Issuer
Stock Option (right to buy)
2015-10-01−8,400→ 0 totalExercise: $33.26Exp: 2024-06-05→ Common Stock (8,400 underlying)
Footnotes (1)
- [F1]Disposed of pursuant to the Amended and Restated Agreement and Plan of Merger dated as of August 4, 2015, by and among Allergan plc (formerly known as Actavis plc) ("Allergan"), Keto Merger Sub, Inc. (a wholly owned subsidiary of Allergan) and Issuer, whereby option to purchase common stock was canceled and paid in cash assuming a stock price of $75.00.
Documents
Issuer
KYTHERA BIOPHARMACEUTICALS INC
CIK 0001436304
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001436304
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 2:19 PM ET
- Size
- 9.8 KB